Is Bronopol safe in cosmetics?
Bronopol has a safety rating of "MODERATE" in our database. EU status: restricted. US status: restricted.
Also known as: 2-Bromo-2-nitro-1,3-propanediol, BRN 1705868, beta-Bromo-beta-nitrotrimethyleneglycol, Bronosol, Caswell No. 116A (+7 more)
INCI: BRONOPOL
Bronopol (CAS 52-51-7) is a cosmetic preservative functioning as Preservative. NOAEL 7 mg/kg bw/day (cross-referenced against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: restricted, max 0.1%; GHS signal word DANGER. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
View industrial chemical safety profile for CAS 52-51-7 →
Bronopol is classified GHS Danger (H301, H302, H312, H315, H318, H331, H335, H400) in the chemicals database but is restricted in EU cosmetics at max 0.1%.
Source: Cosmetics: ingredients.eu_status/eu_max; Chemicals: ghs_classifications.signal_word/hazard_statement_code
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Bronopol.
Calculate MoS for your specific formulation with the MoS Calculator.
Globally Harmonized System classification per ECHA C&L inventory and ILO/WHO International Chemical Safety Cards.
Pre-calculated NOAEL → SED → MoS audit trail for Bronopol across SCCS product categories, with measured dermal absorption where available.
Contact sensitization data for Bronopol based on clinical patch test studies and IFRA standards.
Source: ESSCA 2019/20; IVDK; FDA
Legally binding harmonized classification per Regulation (EC) No 1272/2008 (CLP) Annex VI.
Inserted via ATP: ATP01
Adverse Outcome Pathway data across 5 assays (DPRA, KeratinoSens, hCLAT, LLNA, NESIL) aggregated from public sources.
Source: HPPT: [30] Marzulli FN and Maibach HI (1974): https://doi.org/10.1016/0015-6264(74)90367-8
2 human repeat insult patch tests aggregated from dermatological literature.
| Test Type | N | Sensitized | Dose µg/cm² | NESIL µg/cm² | Potency |
|---|---|---|---|---|---|
| HRIPT | - | 0 | 1395 | - | - |
| HRIPT | - | 0 | 3487.51 | - | - |
Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.
| Endpoint | Target | Value | Direction |
|---|---|---|---|
| ERα and AR receptor transactivation | ERα / AR | EC50/IC50: LOEC ~10 µM (estrogenic); no formal EC50 published; LOEC: 10 µM; NOEC: not established mixed | weak agonist (ER); possible weak AR agonist |
| AhR pathway activation (indirect/low potency) | AhR | EC50/IC50: No formal EC50; marginal activity in some studies at ≥50 µM; LOEC: ~50 µM (estimated); NOEC: not established mixed | weak indirect inducer (via oxidative stress) |
| Steroidogenesis (E2 / T production) | Steroidogenesis (CYP19 / 3βHSD) | EC50/IC50: LOEC ~50 µM (marginal steroidogenic effects at high concentrations); LOEC: ~50 µM (estimated); NOEC: not established mixed | weak modulator |
| Thyroid peroxidase enzyme activity inhibition | Thyroid peroxidase (TPO) | EC50/IC50: IC50 not formally reported; >30% inhibition at 100 µM (rat thyroid microsomes); LOEC: ~50 µM (estimated); NOEC: not determined mixed | inhibitor (via oxidative / halogenating species at high concentrations) |
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
European Commission CosIng database Annex references per Regulation (EC) No 1223/2009.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| CN | permitted_preservative | 0.1 | Rinse-off products |
| CN | permitted_preservative | 0.1 | Rinse-off products |
| IN | permitted_preservative | 0.1 | all cosmetics |
| BR | permitted_preservative | 0.1 | Avoid nitrosamine formation |
| CA | restricted | 0.1% | All cosmetics except amine-containing formulations |
| ASEAN | permitted_preservative | 0.1% | All products |
2 property records from structured ingredient metadata.
Expert safety assessment and concern-level summary for Bronopol.
Public NOAEL study rows linked to Bronopol by CAS number or substance name.
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Bronopol has a safety rating of "MODERATE" in our database. EU status: restricted. US status: restricted.
Bronopol EU regulatory status: restricted. Maximum allowed concentration: 0.1%. This is based on EU Regulation 1223/2009 and its amendments.
Bronopol functions as: Preservative. It is classified as a Preservative in our database. CAS number: 52-51-7.
Bronopol carries a GHS signal word of "DANGER". Hazard statements: Flammable solid Harmful if swallowed or in contact with skin Causes skin irritation Causes serious eye damage May cause respiratory irritation Very toxic to aquatic life with long lasting effects. This classification is based on the ILO/WHO International Chemical Safety Card and ECHA C&L inventory data. Note: GHS classification applies to the pure substance — at cosmetic use concentrations, hazard thresholds may not be met.
Bronopol also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Bronopol is classified GHS Danger (H301, H302, H312, H315, H318, H331, H335, H400) in the chemicals database but is restricted in EU cosmetics at max 0.1%.
Check Bronopol compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Bronopol in your formulation.